Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Generic Drug Industry Scandal: Convicted FDA Reviewer Is Freed From Debarment

This article was originally published in The Pink Sheet Daily

Executive Summary

Twenty-five years after he pled guilty to taking payments from companies, former FDA review chemist David Brancato gets FDA to terminate his debarment; several industry execs won terminations years ago.

Advertisement

Related Content

Insider Trading Bull's-Eye: FDA Chemist Charged With Using Agency's DARRTS NDA Tracking System For Improper Trades

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS078742

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel